These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
244 related items for PubMed ID: 7648936
21. Missense mutations in the PML/RARalpha ligand binding domain in ATRA-resistant As(2)O(3) sensitive relapsed acute promyelocytic leukemia. Marasca R, Zucchini P, Galimberti S, Leonardi G, Vaccari P, Donelli A, Luppi M, Petrini M, Torelli G. Haematologica; 1999 Nov; 84(11):963-8. PubMed ID: 10553155 [Abstract] [Full Text] [Related]
22. Cytogenetics, FISH and RT-PCR analysis of acute promyelocytic leukemia: structure of the fusion point in a case lacking classic t(15;17) translocation. Fujita K, Oba R, Harada H, Mori H, Niikura H, Isoyama K, Omine M. Leuk Lymphoma; 2003 Jan; 44(1):111-5. PubMed ID: 12691149 [Abstract] [Full Text] [Related]
23. Disappearance of PML/RAR alpha acute promyelocytic leukemia-associated transcript during consolidation chemotherapy. Martinelli G, Ottaviani E, Testoni N, Visani G, Diverio D, D'Elia G, Mandelli F, Tura S. Haematologica; 1998 Nov; 83(11):985-8. PubMed ID: 9864917 [Abstract] [Full Text] [Related]
24. Internal tandem duplication and Asp835 mutations of the FMS-like tyrosine kinase 3 (FLT3) gene in acute promyelocytic leukemia. Shih LY, Kuo MC, Liang DC, Huang CF, Lin TL, Wu JH, Wang PN, Dunn P, Lai CL. Cancer; 2003 Sep 15; 98(6):1206-16. PubMed ID: 12973844 [Abstract] [Full Text] [Related]
25. All-trans-retinoic acid in acute promyelocytic leukemia and its potential in other hematologic malignancies. Tallman MS. Semin Hematol; 1994 Oct 15; 31(4 Suppl 5):38-48. PubMed ID: 7831584 [Abstract] [Full Text] [Related]
26. [Retinoic acid receptor alpha gene in t (15; 17) APL]. Takashima T, Misawa S. Nihon Rinsho; 1992 Jun 15; 50(6):1363-8. PubMed ID: 1325570 [Abstract] [Full Text] [Related]
27. Establishing the presence of the t(15;17) in suspected acute promyelocytic leukaemia: cytogenetic, molecular and PML immunofluorescence assessment of patients entered into the M.R.C. ATRA trial. M.R.C. Adult Leukaemia Working Party. Grimwade D, Howe K, Langabeer S, Davies L, Oliver F, Walker H, Swirsky D, Wheatley K, Goldstone A, Burnett A, Solomon E. Br J Haematol; 1996 Sep 15; 94(3):557-73. PubMed ID: 8790159 [Abstract] [Full Text] [Related]
28. Acute promyelocytic leukemia: cellular and molecular basis of differentiation and apoptosis. Chen Z, Wang ZY, Chen SJ. Pharmacol Ther; 1997 Sep 15; 76(1-3):141-9. PubMed ID: 9535176 [Abstract] [Full Text] [Related]
29. Association of PML-RAR alpha fusion mRNA type with pretreatment hematologic characteristics but not treatment outcome in acute promyelocytic leukemia: an intergroup molecular study. Gallagher RE, Willman CL, Slack JL, Andersen JW, Li YP, Viswanatha D, Bloomfield CD, Appelbaum FR, Schiffer CA, Tallman MS, Wiernik PH. Blood; 1997 Aug 15; 90(4):1656-63. PubMed ID: 9269786 [Abstract] [Full Text] [Related]
30. The RAR alpha-PLZF chimera associated with Acute Promyelocytic Leukemia has retained a sequence-specific DNA-binding domain. Sitterlin D, Tiollais P, Transy C. Oncogene; 1997 Mar 06; 14(9):1067-74. PubMed ID: 9070655 [Abstract] [Full Text] [Related]
31. Minimal residual disease detection in acute promyelocytic leukemia by reverse-transcriptase PCR: evaluation of PML-RAR alpha and RAR alpha-PML assessment in patients who ultimately relapse. Grimwade D, Howe K, Langabeer S, Burnett A, Goldstone A, Solomon E. Leukemia; 1996 Jan 06; 10(1):61-6. PubMed ID: 8558940 [Abstract] [Full Text] [Related]
32. [Detection of the PML/RAR alpha rearrangement in acute promyelocytic leukemia using a reverse PCR method]. Barragán E, Bonanad S, López JA, Martín G, Martínez J, Sanz GF, Gomis F, Pérez ML, Senent ML, Larrea L, Bolufer P, Sanz MA. Sangre (Barc); 1996 Jun 06; 41(3):189-94. PubMed ID: 8755206 [Abstract] [Full Text] [Related]
34. The PML/RAR alpha fusion gene in the diagnosis and monitoring of acute promyelocytic leukemia. Diverio D, Riccioni R, Mandelli F, Lo Coco F. Haematologica; 1995 Jun 06; 80(2):155-60. PubMed ID: 7628753 [Abstract] [Full Text] [Related]
36. Pilot study of all-trans retinoic acid as post-remission therapy in patients with acute promyelocytic leukemia. Seiter K, Miller WH, Feldman EJ, Ahmed T, Arlin Z. Leukemia; 1995 Jan 06; 9(1):15-8. PubMed ID: 7845010 [Abstract] [Full Text] [Related]
37. Problems existing in differentiation therapy of acute promyelocytic leukemia (APL) with all-trans retinoic acid (ATRA). Wang ZY, Chen Z, Huang W, Li XS, Lu JX, Huang LA, Zhang FQ, Gu LJ, Ouyang RR, Chen SJ. Blood Cells; 1993 Jan 06; 19(3):633-41; discussion 642-7. PubMed ID: 8018944 [Abstract] [Full Text] [Related]
38. A unique case of acute promyelocytic leukemia showing monocytic differentiation after ATRA (all-trans retinoic acid) therapy. Naeem M, Harrison K, Barton K, Nand S, Alkan S. Eur J Haematol; 2006 Feb 06; 76(2):164-6. PubMed ID: 16405439 [Abstract] [Full Text] [Related]
39. Modulation of IL-8, IL-1 beta, and G-CSF secretion by all-trans retinoic acid in acute promyelocytic leukemia. Dubois C, Schlageter MH, de Gentile A, Balitrand N, Toubert ME, Krawice I, Fenaux P, Castaigne S, Najean Y, Degos L. Leukemia; 1994 Oct 06; 8(10):1750-7. PubMed ID: 7523800 [Abstract] [Full Text] [Related]
40. Microgranular and t(11;17)/PLZF-RARalpha variants of acute promyelocytic leukemia also present the flow cytometric pattern of CD13, CD34, and CD15 expression characteristic of PML-RARalpha gene rearrangement. Rizzatti EG, Portieres FL, Martins SL, Rego EM, Zago MA, Falcão RP. Am J Hematol; 2004 May 06; 76(1):44-51. PubMed ID: 15114596 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]